tetrahydropapaveroline has been researched along with papaveroline in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (87.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brossi, A; Daly, J; Jacobson, AE; Mak, CP; Nimitkitpaisan, Y; Reden, J; Rice, KC; Skolnick, P | 1 |
Alleva, PM; Pala, A | 1 |
Cacchio, M; Data, PG; Di Tano, G; Rolfo, A | 1 |
Biagi, A; Fanfoni, S; Guercini, F; Nico, F | 1 |
Graziani, A; Patrignani, S; Ranieri, A; Russo, O | 1 |
Bacciu, PP; Biglioli, P; Dettori, G; Occhioni, G; Soro, P; Spissu, M; Trignano, M | 1 |
Dostert, P; Iwasa, K; Kawai, M; Maruyama, W; Minami, C; Moriyasu, M; Naoi, M; Sango, K | 1 |
8 other study(ies) available for tetrahydropapaveroline and papaveroline
Article | Year |
---|---|
Mammalian alkaloids. 8. Synthesis and biological effects of tetrahydropapaveroline related 1-benzyltetrahydroisoquinolines.
Topics: Analgesics; Animals; Binding, Competitive; Dihydroalprenolol; Dioxanes; Papaverine; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Spiperone; Stereoisomerism; Structure-Activity Relationship; Tetrahydropapaveroline | 1980 |
[Papaveroline in mental disorders caused by a deficit of non-focalized cerebral circulation].
Topics: Adult; Aged; Cerebrovascular Disorders; Female; Humans; Male; Mental Disorders; Middle Aged; Papaverine; Tetrahydropapaveroline; Vasodilator Agents | 1981 |
Effects of papaveroline-monosulphate on the systemic and regional circulation in the dog.
Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Drug Combinations; Heart Rate; Hemodynamics; Isoxsuprine; Meglumine; Papaverine; Regional Blood Flow; Sorbitol; Stroke Volume; Tetrahydropapaveroline; Vascular Resistance; Vasodilator Agents | 1981 |
[Cerebral ischemic vasculopathy: clinical and thermographic study in patients treated with papaveroline].
Topics: Aged; Brain Ischemia; Female; Humans; Male; Nicergoline; Papaverine; Tetrahydropapaveroline; Vasodilator Agents; Vincamine | 1981 |
[Experience with the use of papaverolina in patients with arterial diseases].
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Blood Flow Velocity; Electrocardiography; Female; Heart; Hemodynamics; Humans; Intracranial Arteriosclerosis; Leg; Male; Middle Aged; Papaverine; Plethysmography, Impedance; Tetrahydropapaveroline | 1981 |
[Raynaud's phenomenon: diagnostic and therapeutic aspects].
Topics: 1-Propanol; Adult; Aspirin; Ergot Alkaloids; Female; Griseofulvin; Humans; Male; Middle Aged; Raynaud Disease; Sympathectomy; Tetrahydropapaveroline; Vasodilator Agents; Xanthinol Niacinate | 1981 |
[Therapeutic aspects of a case of Prinzmetal's angina].
Topics: Aged; Amiodarone; Angina Pectoris; Angina Pectoris, Variant; Drug Therapy, Combination; Electrocardiography; Humans; Male; Nifedipine; Nitrates; Pindolol; Tetrahydropapaveroline | 1980 |
Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3', 4'-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines.
Topics: Apoptosis; Cell Death; Dopamine; Humans; Necrosis; Neuroblastoma; Neurotoxins; Oxidation-Reduction; Tetrahydropapaveroline; Tumor Cells, Cultured | 2000 |